With the analysis among 10,372 patents, we discovered top 477 key players by total patent application. F. Hoffmann-La Roche Ltd., Sanofi-Aventis SA, Novartis AG are dominant in this area. They take 11.90% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 247
Indiana, United States
Patent: 221
Aichi-ken, Japan
Patent: 188
Hessen, Germany
Patent: 172
Hessen, Germany
Patent: 165
Neurocrine Biosciences, Inc.
California, United States
Patent: 149
With the analysis among 89 patents, we discovered top 15 start-ups by total patent application. Biosplice Therapeutics, Inc., Antheia, Inc., Dermavant Sciences GmbH are active in this area.
Biosplice Therapeutics, Inc.
California, United States
Patent: 32
California, United States
Patent: 13
Basel-Stadt, Switzerland
Patent: 10
California, United States
Patent: 7
Escient Pharmaceuticals, Inc.
California, United States
Patent: 6
Genève, Switzerland
Patent: 4
Pathios Therapeutics Ltd.
Shanghai Zhimeng Biopharma, Inc.
Shanghai Shi, China
Patent: 4
Nanjing Fangshenghe Pharmaceutical Technology Co., Ltd.
With the analysis among related 1,759 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Kowa Co., Ltd., Eli Lilly & Co., Neurocrine Biosciences, Inc. take 9.32% of patent filing during this period.
Aichi-ken, Japan
Patent: 60
Indiana, United States
Patent: 57
Neurocrine Biosciences, Inc.
California, United States
Patent: 47
F. Hoffmann-La Roche Ltd.
Aerie Pharmaceuticals, Inc.
New Jersey, United States
Patent: 42
Basel-Stadt, Switzerland
Patent: 40
Xenon Pharmaceuticals, Inc.
British Columbia, Canada
Patent: 38
Les Laboratoires Servier SAS
Hanmi Pharmaceutical Co., Ltd.
D. Western Therapeutics Institute, Inc.
Aichi-ken, Japan
Patent: 25
With the analysis among related 1,759 patents in last 5 years, we discover 335 new entrants. Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 20
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 19
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 19
Beijing Xiahe Technology Co., Ltd.
Beijing Shi, China
Patent: 18
Basel-Stadt, Switzerland
Patent: 10
Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 10
Gelderland, Netherlands
Patent: 9
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 8
Syngenta Crop Protection AG
undefined undefined
Patent: 8
With the analysis among 1,187 patents, we discovered top 256 universities and scientific research institutions by total patent application. University of Vermont, China Pharmaceutical University, Zhejiang University are dominant in this area. They take 11.63% of the total patent filing.
Massachusetts, United States
Patent: 36
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 33
Zhejiang Sheng, China
Patent: 30
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 26
Capital University of Medical Sciences
Beijing Shi, China
Patent: 21
Shanghai Shi, China
Patent: 19
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 16
Sichuan Sheng, China
Patent: 15
Institute Of Cancer Research
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 13